Cardiovascular outcomes of early versus delayed coronary intervention in low to intermediate-risk patients with STEMI in Thailand: a randomised trial
- PMID: 31275432
- PMCID: PMC6579563
- DOI: 10.1136/heartasia-2019-011201
Cardiovascular outcomes of early versus delayed coronary intervention in low to intermediate-risk patients with STEMI in Thailand: a randomised trial
Abstract
Background: The benefit of an early coronary intervention after streptokinase (SK) therapy in low to intermediate-risk patients with ST-elevation myocardial infarction (STEMI) still remains uncertain. The current study aimed to evaluate the cardiovascular outcomes of early versus delayed coronary intervention in low to intermediate-risk patients with STEMI after successful therapy with SK.
Methods: We randomly assigned low to intermediate Global Registry of Acute Coronary Events risk score to patients with STEMI who had successful treatment with full-dose SK at Lampang Hospital and Maharaj Nakorn Chiang Mai Hospital into early and delayed coronary intervention groups. The primary endpoints were 30-day and 6-month composite cardiovascular outcomes (death, rehospitalised with acute coronary syndrome, rehospitalised with heart failure and stroke).
Results: One hundred and sixty-two patients were included in our study. At the 30 days, composite cardiovascular outcomes were 4.9% in the early coronary intervention group and 2.5% in the delayed group (p=0.682). At the 6 months, the composite cardiovascular outcomes were 16.1% in the early group and 6.2% in the delayed group (p=0.054).
Conclusions: The delayed coronary intervention (>24 hours) in low to intermediate STEMI after successful therapy with SK did not increase in short and long-term cardiovascular events compared with an early coronary intervention.
Trial registration number: NCT02131103.
Keywords: ST-elevation myocardial infarction; delayed coronary intervention; early coronary intervention; low to intermediate GRACE risk score; successful streptokinase therapy.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
GRACE score and cardiovascular outcomes prediction among the delayed coronary intervention after post-fibrinolytic STEMI patients in a limited PCI-capable hospital.Open Heart. 2020 Mar 18;7(1):e001133. doi: 10.1136/openhrt-2019-001133. eCollection 2020. Open Heart. 2020. PMID: 32231784 Free PMC article.
-
The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study.BMC Cardiovasc Disord. 2016 Nov 8;16(1):212. doi: 10.1186/s12872-016-0383-3. BMC Cardiovasc Disord. 2016. PMID: 27821064 Free PMC article.
-
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916344 Chinese.
-
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial.Can J Cardiol. 2020 Nov;36(11):1805-1814. doi: 10.1016/j.cjca.2020.01.019. Epub 2020 Jan 25. Can J Cardiol. 2020. PMID: 32798463 Review.
-
Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.Am J Cardiovasc Drugs. 2004;4(2):107-15. doi: 10.2165/00129784-200404020-00004. Am J Cardiovasc Drugs. 2004. PMID: 15049722 Review.
Cited by
-
[Reply yo the letter to the editor : "Keeping an eye on the pharmacoinvasive strategy"].Arch Peru Cardiol Cir Cardiovasc. 2024 Jun 24;5(2):e368. doi: 10.47487/apcyccv.v5i2.368.. eCollection 2024 Apr-Jun. Arch Peru Cardiol Cir Cardiovasc. 2024. PMID: 39015188 Free PMC article. Spanish. No abstract available.
-
The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysis.ARYA Atheroscler. 2024 Mar-Apr;20(2):31-40. doi: 10.48305/arya.2024.42104.2921. ARYA Atheroscler. 2024. PMID: 39170814 Free PMC article.
References
-
- Srimahachota S, Boonyaratavej S, Kanjanavanit R, et al. . Thai Registry in Acute Coronary Syndrome (TRACS)--an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year. J Med Assoc Thai 2012;95:508–18. - PubMed
-
- Wijns W, Kolh P, Danchin N, et al. . Guidelines on myocardial revascularization. the task Force on myocardial revascularization of the European Society of cardiology (ESC) and the European association for Cardio-Thoracic surgery (EACTS). developed with the special contribution of the European association for percutaneous cardiovascular interventions (EAPCI). Eur Heart J 2010;31:2501–55. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical